Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies.
Saved in:
| Title: | Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies. |
|---|---|
| Authors: | El-Maadawy, Walaa H.1 (AUTHOR) w.elmadawy@tbri.gov.eg, Hafiz, Ehab2 (AUTHOR), Tadros, Samer A.3 (AUTHOR), Fahim, Sally A.4 (AUTHOR) sallyatef@hotmail.com, Ebrahim, Haidy M.5 (AUTHOR), Fouad, Marwa A.6,7 (AUTHOR), Attia, Yasmin M.8 (AUTHOR) |
| Source: | Scientific Reports. 6/20/2025, Vol. 15 Issue 1, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
